相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Insulin-resistant cardiomyopathy
Ronald M. Witteles et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure
Jalal K. Ghali et al.
JOURNAL OF CARDIAC FAILURE (2007)
Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials
Rodrigo M. Lago et al.
LANCET (2007)
Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET)
Christian Torp-Pedersen et al.
HEART (2007)
Rosiglitazone evaluated for cardiovascular outcomes - An interim analysis
Philip D. Home et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The impact of thiazolidinedione use on outcomes in ambulatory patients with diabetes mellitus and heart failure
David Aguilar et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Diabetic cardiomyopathy revisited
Sihem Boudina et al.
CIRCULATION (2007)
A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association functional class I or II heart failure
Henry J. Dargie et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine - Consistency across subgroups in the African-American Heart Failure Trial
Anne L. Taylor et al.
CIRCULATION (2007)
Effect of cardiac resynchronization on morbidity and mortality of diabetic patients with severe heart failure
Uta C. Hoppe et al.
DIABETES CARE (2007)
Glucose and haemoglobin in the assessment of prognosis after first hospitalisation for heart failure
J. D. Newton et al.
HEART (2006)
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose:: a randomised controlled trial
H. C. Gerstein et al.
LANCET (2006)
Efficacy and safe of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes - The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN)
Robert H. Knopp et al.
DIABETES CARE (2006)
Diabetes in heart failure: Prevalence and impact on outcome in the population
Aaron M. From et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes - The treating to new targets (TNT) study
James Shepherd et al.
DIABETES CARE (2006)
Diabetes lowers six-minute walk test performance in heart failure
L Ingle et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates - 2006
Mandeep R. Mehra et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2006)
Predictors of mortality and morbidity in patients with chronic heart failure
SJ Pocock et al.
EUROPEAN HEART JOURNAL (2006)
Decreased survival in diabetic patients with heart failure due to systolic dysfunction
M Kamalesh et al.
EUROPEAN JOURNAL OF HEART FAILURE (2006)
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
DM Nathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Hospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studies
AA Carr et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
JA Dormandy et al.
LANCET (2005)
Does carvedilol impair insulin sensitivity in heart failure patients without diabetes?
S Ferrua et al.
JOURNAL OF CARDIAC FAILURE (2005)
Improved clinical outcomes associated with metformin in patients with diabetes and heart failure
DT Eurich et al.
DIABETES CARE (2005)
Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure
W Doehner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Diabetes lowers aerobic capacity in heart failure
AS Tibb et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Comparison of efficacy of implanted cardioverter-defibrillator in patients with versus without diabetes mellitus
SM Wittenberg et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Pioglitazone initiation and subsequent hospitalization for congestive heart failure
AJ Karter et al.
DIABETIC MEDICINE (2005)
Insulin resistance and risk of congestive heart failure
E Ingelsson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure
S Yusuf et al.
CIRCULATION (2005)
The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudy
CA Daly et al.
EUROPEAN HEART JOURNAL (2005)
Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes:: Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA)
PS Sever et al.
DIABETES CARE (2005)
The association of heart failure with insulin resistance and the development of type 2 diabetes
JB Kostis et al.
AMERICAN JOURNAL OF HYPERTENSION (2005)
Prevalence and characteristics of diabetic patients in a chronic heart failure population
C Kistorp et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2005)
The association between glucose abnormalities and heart failure in the population-based Reykjavik study
IS Thrainsdottir et al.
DIABETES CARE (2005)
Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure - An observational study
FA Masoudi et al.
CIRCULATION (2005)
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure
GH Bardy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Retinopathy and risk of congestive heart failure
TY Wong et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Insulin-treated dia betes is associated with a marked increase in mortality in patients with advanced heart failure
S Smooke et al.
AMERICAN HEART JOURNAL (2005)
Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: Experiences from MERIT-HF
PC Deedwania et al.
AMERICAN HEART JOURNAL (2005)
Albuminuria as a predictor of heart failure hospitalizations in patients with type 2 diabetes
ML Hockensmith et al.
JOURNAL OF CARDIAC FAILURE (2004)
Impact of diabetes mellitus on long-term survival in patients with congestive heart failure
P de Groote et al.
EUROPEAN HEART JOURNAL (2004)
Impact of race on health care utilization and outcomes in veterans with congestive heart failure
A Deswal et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure
I Gustafsson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
A multivariate model for predicting mortality in patients with heart failure and systolic dysfunction
JM Brophy et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Heart failure prevalence, incidence, and mortality in the elderly with diabetes
AG Bertoni et al.
DIABETES CARE (2004)
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
HM Colhoun et al.
LANCET (2004)
The incidence of congestive heart failure in type 2 diabetes
GA Nichols et al.
DIABETES CARE (2004)
Combination of isosorbide dinitrate and hydralazine in blacks with heart failure
AL Taylor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension - A randomized controlled trial
GL Bakris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Tolerability of carvedilol and ACE-inhibition in mild heart failure.: Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN)
M Komajda et al.
EUROPEAN JOURNAL OF HEART FAILURE (2004)
Effects of diabetes mellitus and ischemic heart disease on the progression from asymptomatic left ventricular dysfunction to symptomatic heart failure: A retrospective analysis from the Studies of Left Ventricular Dysfunction (SOLVD) Prevention Trial
SR Das et al.
AMERICAN HEART JOURNAL (2004)
Mortality and morbidity reduction with candesartan in patients with chronic heart failure and left ventricular systolic dysfunction - Results of the CHARM low-left ventricular ejection fraction trials
JB Young et al.
CIRCULATION (2004)
Thiazolidinedione use, fluid retention, and congestive heart failure - A consensus statement from the American Heart Association and American Diabetes Association
RW Nesto et al.
CIRCULATION (2003)
The effect of diabetes on outcomes of patients with advanced-heart failure in the BEST trial
M Domanski et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population
I Raymond et al.
HEART (2003)
Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes
V Epshteyn et al.
DIABETES CARE (2003)
Survival and hospitalization in heart failure patients with or without diabetes treated with β-blockers
M Bobbio et al.
JOURNAL OF CARDIAC FAILURE (2003)
Race, quality of care, and outcomes of elderly patients hospitalized with heart failure
SS Rathore et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status - A meta-analysis of major clinical trials
PG Shekelle et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Mechanisms of the free fatty acid-induced increase in hepatic glucose production
TKT Lam et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)
Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure
WHW Tang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Evolving trends in risk profiles and causes of death after heart transplantation: A ten-year multi-institutional study
JK Kirklin et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2003)
Enalapril reduces the incidence of diabetes in patients with chronic heart failure - Insight from the Studies of Left Ventricular Dysfunction (SOLVD)
E Vermes et al.
CIRCULATION (2003)
Development of congestive heart failure in type 2 diabetic patients with microalbuminuria or proteinuria - Observations from the DIABHYCAR (type 2 DIABetes, Hypertension, CArdiovascular Events and Ramipril) study
L Vaur et al.
DIABETES CARE (2003)
Functional class in patients with heart failure is associated with the development of diabetes
A Tenenbaum et al.
AMERICAN JOURNAL OF MEDICINE (2003)
Burden of systolic and diastolic ventricular dysfunction in the community - Appreciating the scope of the heart failure epidemic
MM Redfield et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials
SJ Haas et al.
AMERICAN HEART JOURNAL (2003)
A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 diabetes
MS Sutton et al.
DIABETES CARE (2002)
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
LH Lindholm et al.
LANCET (2002)
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
WC Knowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Effect of non-insulin-dependent diabetes mellitus on pulmonary function and exercise tolerance in chronic congestive heart failure
M Guazzi et al.
AMERICAN JOURNAL OF CARDIOLOGY (2002)
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
JN Cohn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
BM Brenner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study
MK Davies et al.
LANCET (2001)
The prognosis of heart failure in the general population - The Rotterdam Study
A Mosterd et al.
EUROPEAN HEART JOURNAL (2001)
Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure
E Erdmann et al.
EUROPEAN JOURNAL OF HEART FAILURE (2001)
Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction
DL Dries et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Betablocker treatment in diabetes mellitus
PT Sawicki et al.
JOURNAL OF INTERNAL MEDICINE (2001)
A randomized trial of rosiglitazone therapy in patients with inadequately controlled insulin-treated type 2 diabetes
P Raskin et al.
DIABETES CARE (2001)
Effect of carvedilol on survival in severe chronic heart failure.
M Packer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Risk factors for congestive heart failure in US men and women -: NHANES I epidemiologic follow-up study
J He et al.
ARCHIVES OF INTERNAL MEDICINE (2001)
Left ventricular systolic dysfunction in 75-year-old men and women -: A population-based study
P Hedberg et al.
EUROPEAN HEART JOURNAL (2001)
Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus -: Results from the ATLAS trial
L Rydén et al.
EUROPEAN HEART JOURNAL (2000)
Diabetes and outcomes of coronary artery bypass graft surgery in patients with severe left ventricular dysfunction: Results from the CABG Patch Trial database
W Whang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
Evidence of improving prognosis in heart failure - Trends in case fatality in 66 547 patients hospitalized between 1986 and 1995
K MacIntyre et al.
CIRCULATION (2000)
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
IM Stratton et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)
Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure
N Suskin et al.
EUROPEAN HEART JOURNAL (2000)
New insights into sympathetic regulation of glucose and fat metabolism
K Nonogaki
DIABETOLOGIA (2000)
Predictors of congestive heart failure in the elderly: The cardiovascular health study
JS Gottdiener et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
分享论文
